STRO — Sutro Biopharma, Inc.

STROSutro Biopharma, Inc.

NAS · US · Healthcare · Biotechnology · sutrobio.com

27.06USD+5.83%Mkt Cap: 450.55M USDP/E: —Last update: 2026-05-26

Sutro Biopharma, Inc. operates as an oncology company. The company develops site-specific and novel-format antibody drug conjugates (ADCs) that enables its proprietary integrated cell-free protein synthesis platform, Xpr…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap450.55M USD

Enterprise Value211.66M USD

Revenue (TTM)99.61M USD

Gross Profit-66.81M USD

Net Income (TTM)-191.09M USD

Revenue/Share10.29 USD

Last Price27.06 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees137

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-4.45

PEG—

EV/EBITDA-2.65

EV/Revenue2.12

P/S5.09

P/B-1.98

EPS (TTM)-16.35

EPS (Forward)-6.87

52W Range

6.70055% of range43.85

52W High43.85 USD

52W Low6.700 USD

Profitability

Gross Margin-67.07%

Oper. Margin-203.91%

EBITDA Margin-80.15%

Profit Margin-186.45%

ROE144.27%

ROA-109.93%

Growth

Revenue Growth-16.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF-177.23M USD

CapEx (TTM)1.70M USD

FCF Margin—

FCF Yield—

Net Debt-188.93M USD

Net Debt/EBITDA2.37

Balance Sheet

Debt/Equity-0.12

Current Ratio3.25

Quick Ratio3.25

Book Value/Sh-15.4300 USD

Cash/Share15.48 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:10

Split DateDec 3, 2025

Analyst Consensus

Rating1.4 (Strong Buy)

Target (Mean)46.55 USD

Target Range9.000 USD – 61.00 USD

# Analysts11

Ownership

Shares Out.16.57M

Float10.51M

Insiders2.30%

Institutions86.54%

Short Interest

Short Ratio4.0d

Short % Float5.92%

Short % Out.5.90%

Shares Short977.11K

Short (prev mo.)639.71K

Technical

SMA 5030.30 (-10.7%)

SMA 20016.22 (+66.8%)

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)300.71K

Avg Vol (10d)313.50K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—